CRY Financial Facts
Research and development: 3.71MProducts: 28M
See Full Income Statement
Trademarks and other intangibles, net: 66.78M
Total current liabilities: 24.76M
See Full Balance Sheet
CryoLife Inc. (CRY) Earnings
|
Expand Research on CRY
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +366.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +11.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/4/21  |
 |
Q321 | N/A | -$0.02 | N/A | N/A | $72.4M | = | N/A | N/A | |
| 7/29/21 | |
Q221 | $0.12 | -$0.05 | +$0.17 | $76.1M | $70.97M | = |  | | Details |
| 4/29/21 | |
Q121 | $0.03 | -$0.09 | +$0.12 | $71.1M | $62.98M | N/A | | | Details |
| 2/11/21 | |
Q420 | $0.20 | $0.03 | +$0.17 | $67.9M | $66.53M | N/A | | | Details |
| 11/4/20 | |
Q320 | $0.13 | -$0.04 | +$0.17 | $65.1M | $59.24M | N/A | | | Details |
| 7/30/20 | |
Q220 | -$0.02 | -$0.14 | +$0.12 | $53.8M | $50.47M | N/A | | | Details |
| 4/30/20 | |
Q120 | -$0.08 | $0.02 | -$0.10 | $66.4M | $66.01M | N/A | | | Details |
| 2/13/20 | |
Q419 | $0.10 | $0.08 | +$0.02 | $69.7M | $70.82M | N/A | | | Details |
